Kolon TissueGene
Source-claim record: this page may be based on an automated extraction. The figure may describe a plan, an aggregate or overlapping coverage and has not necessarily been independently verified as a completed layoff.
Reported figure
37
(54%)
Reported or extracted reason
U.S. trial failure of osteoarthritis drug TG-C; stock price plunge due to alleged information leak
🔮 Oracle Verdict
This layoff has not yet been scored by the Oracle.
Source provenance
https://biz.chosun.com/en/en-science/2026/08/23/FLBTX5QALZFM3JLQYLJGNPFJVM/?outp…via Google Alerts RSS